Results 201 to 210 of about 63,667 (225)

Tenofovir

Reactions Weekly, 2006
openaire   +2 more sources

Tenofovir

Reactions Weekly, 2003
openaire   +2 more sources

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

Lancet, The, 2021
Shahin Lockman, Lynda Stranix-Chibanda, Lee Fairlie   +2 more
exaly  

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Lancet, The, 2020
Kenneth Mayer, Jean-Michel Molina, Peter L Anderson   +2 more
exaly  

Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate

Clinical Gastroenterology and Hepatology, 2022
Kwan Soo Byun, Jonggi Choi, Han Chu Lee
exaly  

Tenofovir

Reactions Weekly, 2013
openaire   +1 more source

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Lancet, The, 2015
Paul E Sax, Michael T Yin, Fa Post
exaly  

Tenofovir

Reactions Weekly, 2012
openaire   +1 more source

Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide

Journal of Antimicrobial Chemotherapy, 2019
Maddalena Cerrone, Megan Neary, Mark A Marzinke   +2 more
exaly  

Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy

Clinical Infectious Diseases, 2015
Heidi J Kalkwarf, Julia W Wu, Linda A Dimeglio   +2 more
exaly